Key Events This Week
22 Jun: New 52-week high (Rs.153)
22 Jun: All-time high reached (Rs.153)
24 Jun: Golden Cross formation signalling bullish breakout
25 Jun: Week closes at Rs.126.05 (-1.18%)
Aug 12, 03:30 PM
BSE+NSE Vol: 14.38 k

Lotus Eye Hospital & Institute Ltd has experienced a significant change in its valuation parameters, shifting from a risky to an expensive classification. Despite a recent uptick in share price, the company’s elevated price-to-earnings (P/E) and price-to-book value (P/BV) ratios relative to peers and historical averages raise questions about its current price attractiveness for investors.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 03 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 23 July 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 July 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.
Read full news article
Lotus Eye Hospital & Institute Ltd is rated Sell by MarketsMOJO. This rating was last updated on 05 Jun 2026. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 30 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
22 Jun: New 52-week high (Rs.153)
22 Jun: All-time high reached (Rs.153)
24 Jun: Golden Cross formation signalling bullish breakout
25 Jun: Week closes at Rs.126.05 (-1.18%)

The 50-day moving average has crossed above the 200-day moving average for Lotus Eye Hospital & Institute Ltd, signalling a golden cross on 24 Jun 2026. While this technical event often suggests a shift towards bullish momentum, the broader technical and fundamental context must be examined to understand whether this signal stands on firm ground or is contradicted by other data.
Read full news article
Surging to a new 52-week high of Rs 153 on 22 Jun 2026, Lotus Eye Hospital & Institute Ltd has demonstrated remarkable price momentum, outperforming the Sensex by a wide margin over the past year. This milestone caps an 84.87% rally from its 52-week low of Rs 68, underscoring a sustained uptrend fuelled by a confluence of bullish technical indicators.
Read full news articleNewspaper Advertisements published for Standalone Unaudited Financial Results for the quarter ended June 30 2026
Standalone Unaudited Financial Results for the quarter ended June 30 2026.
Approved Standalone Unaudited Financial Results for the quarter ended June 30 2026.
No Upcoming Board Meetings
Lotus Eye Hospital & Institute Ltd has declared 5% dividend, ex-date: 18 Sep 23
No Splits history available
No Bonus history available
No Rights history available